A lack of prognostic significance regarding ΔNp63 immunoreactivity in lung cancer
Authors:
- Hidetaka UramotoHUHidetaka Uramoto
- Kenji SugioKSKenji Sugio
- Yoshihisa FujinoYFYoshihisa Fujino
- Tsunehiro OyamaTOTsunehiro Oyama
- Shoji NakataSNShoji Nakata
- Kenji OnoKOKenji Ono
- Masaru MoritaMMMasaru Morita
- Kosei YasumotoKYKosei Yasumoto
- 1 October 2005
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 50 (1) , 67-73
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (14370420, 14571292, 14657329, 15591460, 15790756, 15790757, 17390388, 17591451)
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 16 references indexed in Scilit:
- Multidisciplinary Management of Lung CancerNew England Journal of Medicine, 2004
- p73 and p63 protein stability: the way to regulate function?Biochemical Pharmacology, 2003
- Differential regulation of p63 and p73 expressionOncogene, 2003
- ΔNp63α functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytesOncogene, 2003
- p73 Independent of c-Myc Represses Transcription of Platelet-derived Growth Factor β-Receptor through Interaction with NF-YJournal of Biological Chemistry, 2002
- p53 associates with and targets ΔNp63 into a protein degradation pathwayProceedings of the National Academy of Sciences, 2001
- Association of p63 with Proliferative Potential in Normal and Neoplastic Human KeratinocytesJournal of Investigative Dermatology, 1999
- Fas expression in non-small cell lung cancerEuropean Journal of Cancer, 1999
- Lonely No More: p53 Finds Its Kin in a Tumor Suppressor HavenCell, 1997
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958